+1 (704) 266-3234

Global Retinal Biosimilars Market Size, Status And Forecast 2019-2025

Published on: Jun 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 96

In 2018, the global Retinal Biosimilars market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Biosimilars development in United States, Europe and China.

The key players covered in this study
Novartis (Sandoz)
Shire
Bayer
Genentech
Pfenex
Reliance Life Sciences
Hetero Drugs
Intas Pharmaceuticals
Santo Holding
Regeneron Pharmaceuticals

Market segment by Type, the product can be split into
Macular Degeneration Drugs
Diabetic Eye Disease Drugs
Macular Pucker Drugs
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players.
To present the Retinal Biosimilars development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinal Biosimilars Market Size Growth Rate by Type (2014-2025)
1.4.2 Macular Degeneration Drugs
1.4.3 Diabetic Eye Disease Drugs
1.4.4 Macular Pucker Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Retinal Biosimilars Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinal Biosimilars Market Size
2.2 Retinal Biosimilars Growth Trends by Regions
2.2.1 Retinal Biosimilars Market Size by Regions (2014-2025)
2.2.2 Retinal Biosimilars Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinal Biosimilars Market Size by Manufacturers
3.1.1 Global Retinal Biosimilars Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinal Biosimilars Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinal Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Biosimilars Key Players Head office and Area Served
3.3 Key Players Retinal Biosimilars Product/Solution/Service
3.4 Date of Enter into Retinal Biosimilars Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinal Biosimilars Market Size by Type (2014-2019)
4.2 Global Retinal Biosimilars Market Size by Application (2014-2019)

5 United States
5.1 United States Retinal Biosimilars Market Size (2014-2019)
5.2 Retinal Biosimilars Key Players in United States
5.3 United States Retinal Biosimilars Market Size by Type
5.4 United States Retinal Biosimilars Market Size by Application

6 Europe
6.1 Europe Retinal Biosimilars Market Size (2014-2019)
6.2 Retinal Biosimilars Key Players in Europe
6.3 Europe Retinal Biosimilars Market Size by Type
6.4 Europe Retinal Biosimilars Market Size by Application

7 China
7.1 China Retinal Biosimilars Market Size (2014-2019)
7.2 Retinal Biosimilars Key Players in China
7.3 China Retinal Biosimilars Market Size by Type
7.4 China Retinal Biosimilars Market Size by Application

8 Japan
8.1 Japan Retinal Biosimilars Market Size (2014-2019)
8.2 Retinal Biosimilars Key Players in Japan
8.3 Japan Retinal Biosimilars Market Size by Type
8.4 Japan Retinal Biosimilars Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinal Biosimilars Market Size (2014-2019)
9.2 Retinal Biosimilars Key Players in Southeast Asia
9.3 Southeast Asia Retinal Biosimilars Market Size by Type
9.4 Southeast Asia Retinal Biosimilars Market Size by Application

10 India
10.1 India Retinal Biosimilars Market Size (2014-2019)
10.2 Retinal Biosimilars Key Players in India
10.3 India Retinal Biosimilars Market Size by Type
10.4 India Retinal Biosimilars Market Size by Application

11 Central & South America
11.1 Central & South America Retinal Biosimilars Market Size (2014-2019)
11.2 Retinal Biosimilars Key Players in Central & South America
11.3 Central & South America Retinal Biosimilars Market Size by Type
11.4 Central & South America Retinal Biosimilars Market Size by Application

12 International Players Profiles
12.1 Novartis (Sandoz)
12.1.1 Novartis (Sandoz) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinal Biosimilars Introduction
12.1.4 Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2014-2019)
12.1.5 Novartis (Sandoz) Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinal Biosimilars Introduction
12.2.4 Shire Revenue in Retinal Biosimilars Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinal Biosimilars Introduction
12.3.4 Bayer Revenue in Retinal Biosimilars Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Genentech
12.4.1 Genentech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinal Biosimilars Introduction
12.4.4 Genentech Revenue in Retinal Biosimilars Business (2014-2019)
12.4.5 Genentech Recent Development
12.5 Pfenex
12.5.1 Pfenex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinal Biosimilars Introduction
12.5.4 Pfenex Revenue in Retinal Biosimilars Business (2014-2019)
12.5.5 Pfenex Recent Development
12.6 Reliance Life Sciences
12.6.1 Reliance Life Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinal Biosimilars Introduction
12.6.4 Reliance Life Sciences Revenue in Retinal Biosimilars Business (2014-2019)
12.6.5 Reliance Life Sciences Recent Development
12.7 Hetero Drugs
12.7.1 Hetero Drugs Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinal Biosimilars Introduction
12.7.4 Hetero Drugs Revenue in Retinal Biosimilars Business (2014-2019)
12.7.5 Hetero Drugs Recent Development
12.8 Intas Pharmaceuticals
12.8.1 Intas Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinal Biosimilars Introduction
12.8.4 Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)
12.8.5 Intas Pharmaceuticals Recent Development
12.9 Santo Holding
12.9.1 Santo Holding Company Details
12.9.2 Company Description and Business Overview
12.9.3 Retinal Biosimilars Introduction
12.9.4 Santo Holding Revenue in Retinal Biosimilars Business (2014-2019)
12.9.5 Santo Holding Recent Development
12.10 Regeneron Pharmaceuticals
12.10.1 Regeneron Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Retinal Biosimilars Introduction
12.10.4 Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)
12.10.5 Regeneron Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Retinal Biosimilars Key Market Segments
Table Key Players Retinal Biosimilars Covered
Table Global Retinal Biosimilars Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Retinal Biosimilars Market Size Market Share by Type 2014-2025
Figure Macular Degeneration Drugs Figures
Table Key Players of Macular Degeneration Drugs
Figure Diabetic Eye Disease Drugs Figures
Table Key Players of Diabetic Eye Disease Drugs
Figure Macular Pucker Drugs Figures
Table Key Players of Macular Pucker Drugs
Figure Others Figures
Table Key Players of Others
Table Global Retinal Biosimilars Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Retinal Biosimilars Report Years Considered
Table Global Retinal Biosimilars Market Size 2014-2025 (Million US$)
Figure Global Retinal Biosimilars Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinal Biosimilars Market Size by Regions 2014-2025 (Million US$)
Table Global Retinal Biosimilars Market Size by Regions 2014-2019 (Million US$)
Table Global Retinal Biosimilars Market Share by Regions 2014-2019
Figure Global Retinal Biosimilars Market Share by Regions 2014-2019
Figure Global Retinal Biosimilars Market Share by Regions 2019
Table Market Top Trends
Table Global Retinal Biosimilars Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Share by Manufacturers (2014-2019)
Figure Global Retinal Biosimilars Market Share by Manufacturers in 2018
Table Global Retinal Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinal Biosimilars Product/Solution/Service
Table Date of Enter into Retinal Biosimilars Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Size Share by Type (2014-2019)
Figure Global Retinal Biosimilars Market Size Market Share by Type (2014-2019)
Table Global Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Size Share by Application (2014-2019)
Figure Global Retinal Biosimilars Market Size Market Share by Application (2014-2019)
Figure Global Retinal Biosimilars Revenue Market Share by Application in 2018
Figure United States Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table United States Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table United States Key Players Retinal Biosimilars Market Share (2018-2019)
Table United States Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table United States Retinal Biosimilars Market Share by Type (2014-2019)
Table United States Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table United States Retinal Biosimilars Market Share by Application (2014-2019)
Figure Europe Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinal Biosimilars Market Share (2018-2019)
Table Europe Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Europe Retinal Biosimilars Market Share by Type (2014-2019)
Table Europe Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Europe Retinal Biosimilars Market Share by Application (2014-2019)
Figure China Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table China Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table China Key Players Retinal Biosimilars Market Share (2018-2019)
Table China Retinal Biosimilars Market Size by Type (2014-20189) (Million US$)
Table China Retinal Biosimilars Market Share by Type (2014-2019)
Table China Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table China Retinal Biosimilars Market Share by Application (2014-2019)
Figure Japan Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Japan Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Japan Key Players Retinal Biosimilars Market Share (2018-2019)
Table Japan Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Japan Retinal Biosimilars Market Share by Type (2014-2019)
Table Japan Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Japan Retinal Biosimilars Market Share by Application (2014-2019)
Figure Southeast Asia Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Retinal Biosimilars Market Share (2018-2019)
Table Southeast Asia Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Retinal Biosimilars Market Share by Type (2014-2019)
Table Southeast Asia Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Retinal Biosimilars Market Share by Application (2014-2019)
Figure India Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table India Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table India Key Players Retinal Biosimilars Market Share (2018-2019)
Table India Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table India Retinal Biosimilars Market Share by Type (2014-2019)
Table India Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table India Retinal Biosimilars Market Share by Application (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Retinal Biosimilars Market Share (2018-2019)
Table Central & South America Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Central & South America Retinal Biosimilars Market Share by Type (2014-2019)
Table Central & South America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Central & South America Retinal Biosimilars Market Share by Application (2014-2019)
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2014-2019) (Million US$)
Figure Novartis (Sandoz) Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Novartis (Sandoz) Recent Development
Table Shire Company Details
Table Shire Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Shire Recent Development
Table Bayer Company Details
Table Bayer Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Bayer Recent Development
Table Genentech Company Details
Table Genentech Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Genentech Recent Development
Table Pfenex Company Details
Table Pfenex Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Pfenex Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Pfenex Recent Development
Table Reliance Life Sciences Company Details
Table Reliance Life Sciences Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Reliance Life Sciences Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Reliance Life Sciences Recent Development
Table Hetero Drugs Company Details
Table Hetero Drugs Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Hetero Drugs Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Hetero Drugs Recent Development
Table Intas Pharmaceuticals Company Details
Table Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Intas Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Intas Pharmaceuticals Recent Development
Table Santo Holding Company Details
Table Santo Holding Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Santo Holding Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Santo Holding Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Global Retinal Biosimilars Market Size by Regions (Million US$) 2019-2025
Figure Global Retinal Biosimilars Market Size Share by Regions (2019-2025)
Figure Global Retinal Biosimilars Market Size Share by Regions in 2025
Figure United States Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure China Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Japan Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure India Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Table Global Retinal Biosimilars Market Size by Product (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Product (2019-2025)
Figure Global Retinal Biosimilars Market Size by Product in 2025
Table Global Retinal Biosimilars Market Size by Application (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Application (2019-2025)
Figure Global Retinal Biosimilars Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.